Yvette Andersson

Yvette Andersson serves as a Postdoctoral Fellow and Senior Surgeon at Uppsala University's Faculty of Medicine, specifically within the Center for Clinical Research, Västmanland. Her clinical work is centered at Västmanland Hospital in Västerås, Sweden, where she maintains active surgical practice alongside academic research.

Her research focuses on optimizing surgical management of breast cancer, particularly regarding axillary lymph node dissection protocols. Key interests include micrometastases handling, ER+HER2- subtype management, sentinel lymph node biopsy accuracy, and long-term recurrence patterns. Her work bridges clinical practice with evidence-based guideline development through large-scale trials.

Analysis of her 15 most recent publications reveals a dominant focus on the SENOMAC and SENOMIC trials, which have redefined axillary management in breast cancer. These studies demonstrate consistent themes: surgical de-escalation without compromising oncological safety, subgroup-specific treatment protocols, and rigorous quality assessment in multicenter trials. The research spans surgical technique refinement, predictive modeling, and long-term outcome monitoring.

While no specific awards are documented in the source material, her publications in top-tier journals including The Lancet Oncology, JAMA Surgery, and New England Journal of Medicine indicate significant scholarly impact. Her work has influenced clinical guidelines and generated substantial real-world evidence adoption.

Andersson collaborates extensively within Sweden's national breast cancer research network, particularly with the SENOMAC trial consortium. Her research directly informs clinical practice, with implications for reducing unnecessary surgeries while maintaining survival outcomes. Current work emphasizes personalized treatment pathways based on nodal metastatic burden and molecular subtypes.